Key facts
- This page summarizes Lee Scott Golden's Form 3 filing for Cadrenal Therapeutics, Inc. (CVKD).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Dec 2025, 20:07.
Lee Scott Golden - 24 Nov 2025 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)
- Reporting relationship
- Director
- Issuer ticker
- CVKD
- Reported as of
- 24 Nov 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 Dec 2025, 20:07:37 UTC
- Prior SEC filing
- 04 Apr 2025
- Next SEC filing
- 03 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew K. Szot, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lee Scott Golden filed Form 3 for Cadrenal Therapeutics, Inc. (CVKD) on 03 Dec 2025.
Change
- Previous filing in this sequence was filed on 04 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001686217
Primary reporting owner
Golden Lee Scott
- Relationship
- Director
- Address
- C/O CADRENAL THERAPEUTICS, INC.,, 822 A1A NORTH, SUITE 306, PONTE VEDRA
- Signature
- /s/ Matthew K. Szot, Attorney-in-fact
- Signature date
- 03 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVKD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,667
- Date
- 24 Nov 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit List - Exhibit 24- Power of Attorney